Projects

RNDr. Martina Labudová, PhD.

National

Current
  • Development of albumin and dendrimer-based nanosystems against tick-borne encephalitis virus
    Program: SRDA
    Duration: 1. 9. 2024 – 30. 6. 2028
Finished
  • Regulation of pyruvate dehydrogenase kinase 1 activity in the control of glycolytic metabolism in hypoxic tumors
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • The analysis of bioactive substances associated with Murine herpesvirus with antiproliferative and immunomodulatory properties in vitro and in vivo
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Interaction of hypoxia with the signaling pathways implicated in differentiation, tumor progression and metastasis.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Graphene - based nanoplatform for detection of cancer
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • The role of carbonic anhydrase IX in tumor metabolism: regulation, function and clinical significance
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Molecular mechanisms of the crosstalk between stress hormones and hypoxia in tumor cells: effect on expression and function of cancer-related protein CA IX
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Characterisation of some mechanisms of persistence and spreading of the lymphocytic choriomeningitis virus
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Identification of the cellular proteins affected by persistent infection with lymphocytic choriomeningitis virus
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • The role of carbonic anhydrase IX in cell migration as a part of metastatic cascade.
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Identification of the molecular pathways driven by hypoxia-induced carbonic anhydrase IX in tumor cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Industrial Research in Clinical Diagnostics of Infectious Pathogens
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2010 – 31. 5. 2013
  • Significance of the carbonic anhydrase IX as a non-invasive prognostic indicator and a molecular target in renal cell carcinoma
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Prevalence and medical significance of lymphocytic choriomeningitis virus in Slovak population
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Regulation of expression and role of TEM1/endosialin/CD248, a potential marker of tumor angiogenesis
    Program: VEGA
    Duration: 1. 1. 2006 – 31. 12. 2008
  • Interplay between lymphocytic choriomeningitis virus and cellular proteins during the persistent infection
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees